Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Life (Basel, Switzerland)|March 6, 2021
Therapeutic Potentials of Syzygium fruticosum Fruit (Seed) Reflected into an Array of Pharmacological Assays and Prospective Receptors-Mediated PathwaysJannatul Nasma Rupa Moni, Md Adnan, Abu Montakim Tareq, et al.
Foods (Basel, Switzerland)|September 9, 2022
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver DiseaseMin Kyo Jeong, Byeong Hyun Min, Ye Rin Choi, et al.
Cells|September 23, 2022
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology StudyKi-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, et al.
Scientific Reports|January 13, 2023
The identification of metabolites from gut microbiota in NAFLD via network pharmacologyKi-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 2, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysisKi-Kwang Oh, Haripriya Gupta, Raja Ganesan, et al.
Journal of Microbiology (Seoul, Korea)|March 5, 2025
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver diseaseSang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
International Journal of Molecular Sciences|August 26, 2022
The Link between Gut Microbiota and Hepatic EncephalopathySung-Min Won, Ki Kwang Oh, Haripriya Gupta, et al.
Artificial Cells, Nanomedicine, and Biotechnology|April 30, 2024
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysisSu-Been Lee, Haripriya Gupta, Byeong-Hyun Min, et al.
Artificial Cells, Nanomedicine, and Biotechnology|December 23, 2022
New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology studyKi-Kwang Oh, Ickwon Choi, Haripriya Gupta, et al.
Gut Microbes|February 1, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammationByeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Pageof 6